Evidence map›Paper›PMID 40276632›Full record

ArticleGynecologic oncology reports2025

Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaire.

Eric D Helm, Cam Nguyen, Stephen Rotholz, Saketh R Guntupalli, Barbara A Goff, Benjamin G Bitler, Kian Behbakht

Abstract read
In one paragraph

Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eric D HelmUniversity of Colorado, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.
Cam NguyenUniversity of Colorado, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.
Stephen RotholzUniversity of Colorado, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.
Saketh R GuntupalliUniversity of Colorado, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.
Barbara A GoffUniversity of Washington, Department of Obstetrics and Gynecology.
Benjamin G BitlerUniversity of Colorado, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.
Kian BehbakhtUniversity of Colorado, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Symptoms occur in up to 75% of patients with early-stage ovarian cancer; as such, using a symptom inventory (SI) to stratify which patients should receive screening for ovarian cancer is an attractive approach to mitigate false-positives. We report on the feasibility and results of a prospective four-question SI that assessed the following symptoms: abdominal pain, bloating, early satiety, and urinary complaints. Frequency and duration of symptoms were not assessed. Methods: A SI was added to the standard pre-appointment check-in process via the electronic medical record's (EMR) patient portal for all annual or new patient visits in a generalist obstetrics and gynecology faculty practice in patients over 40 years of age. IRB exemption was granted. Data were extracted from the EMR, compiled in REDCap, and analyzed in R. Results: A total of 589 individual patients were included in the final analysis. The median age of the participants was 50 years (range: 40-86). 27.8 % of patients experienced at least one symptom in the prior year, and the most commonly reported symptom was urinary urgency/frequency (14.9 %). Patients with a history of medical comorbidities such as depression, uterine fibroids, endometriosis, and irritable bowel syndrome were more likely to screen positive on the SI. No cancers have been diagnosed to date. Conclusions: Implementing a SI using the EMR is feasible but is influenced by the presence of pre-existing diagnoses. The effectiveness of an EMR-based SI pre-screen as a selection criterion for early detection requires further study and assessment of frequency and duration of symptoms should be considered.

Identifiers

PMID40276632
PMCPMC12018059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.